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Methods of Monitoring Cell Fate and Tissue Growth
in Three-Dimensional Scaffold-Based Strategies
for In Vitro Tissue Engineering
Anne M. Leferink, PhD,1–3 Clemens A. van Blitterswijk, PhD,1,2 and Lorenzo Moroni, PhD1,2
In the field of tissue engineering, there is a need for methods that allow assessing the performance of tissue-
engineered constructs noninvasively in vitro and in vivo. To date, histological analysis is the golden standard to
retrieve information on tissue growth, cellular distribution, and cell fate on tissue-engineered constructs after
in vitro cell culture or on explanted specimens after in vivo applications. Yet, many advances have been made to
optimize imaging techniques for monitoring tissue-engineered constructs with a sub-mm or mm resolution.
Many imaging modalities have first been developed for clinical applications, in which a high penetration depth
has been often more important than lateral resolution. In this study, we have reviewed the current state of the art
in several imaging approaches that have shown to be promising in monitoring cell fate and tissue growth upon
in vitro culture. Depending on the aimed tissue type and scaffold properties, some imaging methods are more
applicable than others. Optical methods are mostly suited for transparent materials such as hydrogels, whereas
magnetic resonance-based methods are mostly applied to obtain contrast between hard and soft tissues re-
gardless of their transparency. Overall, this review shows that the field of imaging in scaffold-based tissue
engineering is developing at a fast pace and has the potential to overcome the limitations of destructive endpoint
analysis.
Introduction
The field of tissue engineering has been quickly grow-ing for more than two decades. Numerous approaches for
several applications have been under investigation and various
challenges related to cell fate control, biocompatibility, and
structural integrity of tissue-engineered constructs among oth-
ers have been overcome. Currently, the quality of engineered
tissue constructs is mostly assessed by conventional destructive
methods such as histological analysis.1 However, this approach
results in the assessment of cell activity and produced extra-
cellular matrix (ECM) only at the end of cultures so that the
culture period is still treated as a black box with limited pos-
sibilities to steer culture conditions in a rational manner.
Data obtained by real-time nondestructive methods often
lack spatiotemporal information since these methods treat a
tissue-engineered construct as a bulk material.2 Therefore,
there is a growing interest in novel methods to be able to
nondestructively, and ideally noninvasively, assess the per-
formance of tissue-engineered constructs with a sufficient
spatiotemporal resolution upon in vitro culture before im-
plantation.3–5 By gaining more insights in cell fate and tis-
sue growth during culture, higher efficiencies and faster
procedures could be realized.
Tissue engineering approaches can be generally divided
into two main classes, which consist of (1) cell-based ap-
proaches without the presence of any supporting material and
(2) combinatorial approaches in which cells are introduced
into biological or synthetic materials supporting proliferation
or differentiation. In this review, we will outline current
methodologies and challenges with respect to the character-
ization of this second class of combinatorial scaffold-based
tissue engineering approaches. We will specifically focus on
the applicability of imaging modalities to assess cell fate
when cultured on scaffolds fabricated of solid materials for
musculoskeletal tissue engineering approaches.
Recent reviews have been published on studies that have
addressed the importance of nondestructive assessment of
tissue constructs’ quality by the application of imaging
methods.6–10 However, the majority of these studies focus
on scaffolds’ geometry characterization before cell seeding
in vitro or cell labeling and tracking after implantation
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in vivo.11 These in vitro and in vivo studies unfortunately do
not all address other challenges faced when monitoring the
scaffolds combined with cells in vitro.
The limited penetration depth for most microscopy tech-
niques forms one of these major constraints.12 Conventional
imaging techniques such as laser confocal microscopy or
transillumination microscopy require the use of thin samples
or suffer from spatial resolution, respectively, to study the
cell–scaffold interaction, cellular distribution, and prolifera-
tion during scaffold population.12 So, the applicability of
imaging modalities highly depends on the type of scaffold
used and the biological components to be detected.
First, we will highlight some of the most used scaffold
materials and fabrication methods and their limitations with
respect to monitoring tissue growth, cell fate, and/or cell me-
tabolism. Second, we will summarize conventional methods
for tissue growth, cell fate, and cell metabolism assessment.
Subsequently, imaging modalities, which are potential
candidates to monitor the previously mentioned parameters,
will be introduced.
Scaffold-Based Tissue Engineering
In scaffold-based tissue engineering, biological or syn-
thetic materials are processed into three-dimensional (3D)
constructs or particles that enable cell growth within the
final structure. Depending on the nature of these materials,
the constructs can be hydrogel based or comprise solids.
Hydrogels mostly retain optical transparency, whereas many
solid scaffolding materials can be autofluorescent, semi-
transparent, or opaque. These differences in optical prop-
erties obviously result in different challenges faced when
monitoring cell fate, tissue growth, and cell metabolism by
imaging modalities. In this study, we will shortly outline
two classes of conventional scaffold materials, followed by
scaffold fabrication methods that have shown their rele-
vance in musculoskeletal tissue engineering.
Scaffold materials
Natural materials. In many tissue engineering ap-
proaches, natural materials such as bioceramics, bioglasses,
and biopolymers have gained interest because of their che-
mical properties, processability, and availability.13 Biolo-
gical materials can be divided in several classes, namely
materials retrieved from inorganic materials or plants, from
animal species (xenogeneic), or from allogeneic and auto-
logous sources. Generally, when materials for scaffolds are
retrieved from inorganic substances or a plant, a certain
component is isolated and purified, after which, in most
cases, the macrostructure will be lost.
Materials of interest vary from relatively brittle and stiff
materials such as ceramics to relatively soft materials such
as biopolymers, which can be processed into hydrogels.
Some commonly used bioceramics such as hydroxyapatites
find their potential in bone tissue engineering because of
their known osteoconductive and/or osteoinductive proper-
ties.14–17 Biopolymers, which can be divided in polysac-
charides, proteins, and polyesters, are also of interest in
several tissue engineering approaches.18 For example, in
cartilage tissue engineering research, hydrogels comprising
collagen, alginate, hyaluronic acid, or chitosan, among
others, are widely applied as ECM-mimetic materials.19–26
Furthermore, silk, marine shells, and corals have been used
as sources for biological materials in several tissue engi-
neering approaches.27–32 Bioceramics are crystalline and
therefore opaque materials, whereas bioglasses and bio-
polymers are semicrystalline or fully amorphous, permitting
a certain degree of transillumination.
Decellularized ECM scaffolds from xenogeneic, allogeneic,
or autologous sources are opted as promising nonimmunogenic
materials for several tissue engineering approaches since their
composition mimics the native tissues to a great extent.33–36
However, it is well known that the structure of the native
ECM may be modified or even disrupted in the decellular-
ization process.37,38 Therefore, in soft tissue engineering,
these obtained ECM components are mostly processed as a
hydrogel,39–42 which offers a matrix for cell encapsulation
and permits cell fate monitoring by optical imaging modali-
ties. In other works, some scaffold fabrication techniques
such as electrospinning have been applied to regain cell-
instructive structural elements of the native ECM after de-
cellularization, which leads to the fabrication of nanofiber
meshes mimicking the structure of native ECM.43–45
For musculoskeletal tissue engineering and especially bone
tissue engineering, hard tissue replacements are favored, which
will require sufficient mechanical stability and structural
integrity to sustain the loading conditions in the implanta-
tion site. Therefore, combinatorial approaches of synthetic
materials with decellularized ECM have been investigated
to retain both the native tissue properties of the ECM
components and the mechanical properties of the (synthetic)
scaffold material.46–48 Several processes of decellularization
and their tissue sources and applications are well reviewed
elsewhere.49–52
Synthetic materials and composites. Synthetic materials
represent a large class of widely used materials in tissue
engineering approaches. Upon material synthesis, mechan-
ical properties, surface chemistry, and degradability can be
tailored. Furthermore, synthetic materials are generally
easily processed into scaffolds by various methods, which
will be outlined in the next section. Synthetic polymers have
received considerable attention and are widely studied in
cartilage and bone tissue engineering.53 Natural polymers
are often difficult to process and pathogenic risks may be
involved with natural polymers retrieved from xenogeneic
or allogeneic sources. Synthetic polymers exclude these
drawbacks and exhibit tailorable, predictable, and repro-
ducible physical, chemical, and degradation properties.54
Depending on several parameters such as the degree of
branching, hydrophilicity, and molecular weight of the
polymer, synthetic polymers can be processed both as hy-
drogels and as solid materials. Some well-known polymers
used for hydrogel fabrication are poly(acrylic acid),
poly(ethylene oxide) (PEO), poly(vinyl alcohol), and poly-
peptides.55 Examples of the most popular and most widely
studied biodegradable synthetic polymers in bone tissue
engineering are poly-L-(lactic acid) (PLA), poly(glycolic
acid) (PGA), and their copolymers poly-(lactic-co-glycolic
acid) (PLGA).53,56 Furthermore, other synthetic polymers
have been investigated for cartilage and bone reconstruction
such as poly-(ethylene glycol) (PEG)-based polymers,57,58
poly-e-(caprolactone) (PCL),59 polycarbonates,60 poly-
fumarates,61 polyanhydrides,62 and poly-(ethylene oxide





















































copolymers or blends thereof.64,65
Even though many polymer materials have been synthe-
sized and investigated, to date, no single polymer can
meet all the requirements set for scaffolds in cartilage and
bone tissue engineering.64 All polymers have their own
characteristics, benefits, and drawbacks. Composite materi-
als often show improved characteristics compared with their
individual components with a sufficient balance between
strength and toughness. Taking into account the composition
of native bone, in which both organic and inorganic com-
ponents are found, makes composite materials a logical
choice for bone tissue engineering scaffolds.53,66 Combi-
natorial approaches, in which synthetic materials are used
together with biological materials, offer both a high degree
of tailorability in mechanical properties and enhanced in-
structive properties due to their biological activity.67,68
These instructive properties can result in enhanced cell at-
tachment, proliferation, and differentiation.18,48,69–73
Similar to decellularized matrices and biological materi-
als, the optical properties of scaffolds made of synthetics are
dependent on their crystallinity, autofluorescent properties,
absorption coefficient, processed geometry or porosity, and
scaffold dimensions.
Scaffold fabrication methods
In the past two decades, a library of scaffold fabrication
methods for tissue engineering applications has been de-
veloped. For nearly all common scaffold-based applications,
reviews on fabrication processes can be found.54,74 In a
review from Weigel et al., several commonly used fabri-
cation methods are outlined with examples of specific ap-
plications per method.75 In the following section, we will
shortly introduce not only some well-known methods but
also some recently developed scaffold fabrication methods
and their implications in imaging methods. A resulting ex-
ample from each method is given in Figure 1.
Phase separation methods. One of the earliest scaffold
fabrication processes is based on phase separation principles
(Fig. 1A). The methods and parameters in phase separation
processes have been reviewed recently.76 Highly porous
scaffolds obtained by phase separation techniques find their
use in a broad range of applications from soft scaffolds to
study vascularization to sponge-like constructs for cartilage
regeneration and stiff scaffolds for bone tissue engineer-
ing.77–80 The porosities obtained by these fabrication methods
vary per polymer type and concentration, but mostly range
from *60% to 97.5%.76
The morphology of the obtained pores is often torturous,
irregular, and the pores generally show a large pore size dis-
tribution up to 10-fold within one construct. Generally, the
pore sizes can range from submicrometer to a few hundred
microns and are, besides the degree of interconnectivity,
largely dependent on the applied chemicals and the process
parameters.76 One specific benefit of phase separation meth-
ods is the possibility to create longitudinal pore shapes81 or to
introduce pore size gradients within the scaffold.82
The transparency of the material used will be a major
determinant in the applicability of optical imaging tech-
niques. Yet, even with transparent materials, the torturous
geometry of the pores introduces many interfaces in the
optical path, which will inevitable result in enhanced
scatter and diffraction. The high porosity, and therewith
low bulk density of these constructs, is expected to com-
plicate imaging by nonoptical methods. Specifically,
methods in which contrast is based on the material’s nature
with a spatial resolution limited to several microns will
FIG. 1. Resulting scaffold structures from various fabrication methods. (A) Thermally induced phase separation method
applied on a 7% solution of poly(caprolactone) in 1,4-dioxane. (B) Salt-leached scaffolds of poly-(lactic-co-glycolic acid).
(C) Fused deposition-modeled scaffolds of PEOT/PBT. (D) Electrospun meshes of PEOT/PBT. (E) Sintered tricalcium
phosphate discs. (F) SU-8 micro-objects assembled by hMSCs into porous aggregates. PEOT/PBT, poly-(ethylene oxide
terephthalate)/poly-(butylene terephthalate).




















































suffer from the limited thickness of the material layers that
are separating the pores.
Particle leaching. Particle leaching methods result in 3D
porous matrices, in which the pore sizes are controlled by
the size of the particles (typically in the order of tens to
hundreds of microns) and the porosity and interconnectivity
are determined by the concentration of particles per scaffold
volume (Fig. 1B).83–86 Particle-leached scaffolds are fabri-
cated by casting a solution of a ceramic or polymer, for
example, with solid particles.83,87 After the casted solution
turned solid by evaporation of the solvent or by cooling
down under the melting temperature, fully solid constructs
are retrieved. Subsequently, the particles are leached out by
immersing the full construct in a solvent for the particles,
but a nonsolvent for the chosen polymer. This results in
scaffolds with porosities in the range of 30% to 98%.88 The
most commonly used particles are sugar or salt based be-
cause of their good solubility in water.
The types of scaffolds retrieved with this method are
besides many other applications also widely applied in mus-
culoskeletal tissue engineering, membrane-like scaffolds for
urological purposes, and in in vitro vascularization research.89
The limitations in imaging these types of scaffolds are similar
to those of scaffolds fabricated by phase separation methods.
This similarity is caused by the comparable nature of the
scaffold’s geometry, introducing many thin layers per vol-
ume in highly porous scaffolds.
Additive manufacturing. Additive manufacturing tech-
niques allow researchers to generate scaffolds with outer
geometries based on computer-aided design (CAD).90–92
The field of additive manufacturing includes fused deposi-
tion modeling of thermoplastic materials,93–95 3D printing of
pastes or liquids,96 selective laser sintering (SLS),97–100 and
stereolithography applied to photosensitive materials.101–104
Additive manufacturing techniques gained interest because
of the capability to create scaffold geometries with well-
defined parameters and high reproducibility (Fig. 1C).74
This results in scaffolds with porosities and pore size vir-
tually ranging in the whole possible spectrum. Typically,
manufactured scaffolds with porosities from 30% to 95%
and with pore size ranging from tens of microns to milli-
meters have been reported.74 Another degree of freedom is
enabled by the stepwise or layer-by-layer processing in
additive manufacturing methods, which allows combining
multiple materials into one construct.
Due to the often relatively large pores and the geometries
introduced by these methods, many scaffolds only block the
applicability of imaging methods to a certain extent, even if
the materials are opaque. One can imagine that the regular
structure of the construct enables observations through lon-
gitudinal pores. When transparent materials are used, the
number of interfaces that optical light will have to cross is
much lower than for scaffolds produced with phase separation
or particle leaching methods. However, high resolution at
greater imaging depths will still be limited, mainly due to the
numerical aperture of the objectives that will be utilized.
Electrospinning. Electrospinning (ES) is a commonly
used scaffold fabrication process to obtain nano- to micro-
fiber meshes with high porosities, mimicking the collage-
nous morphology of native ECM (Fig. 1D).105–107 The
method is based upon charging a solution of a chosen ma-
terial and subsequent extrusion through a capillary tip or
needle. A jet is drawn from the needle toward a collector
due to the presence of an electric field. Varying process
parameters such as electric field strength distance between
needle and collector, polymer concentration, and extrusion
speed allow tuning of the fiber diameter and morphology.
Fabricated scaffolds are typically meshes or membranes with
porosities varying from 80% to 99%, but with small pore
sizes typically in the range of tens of nanometers till tens of
micrometers.106 Since the ES process is mostly applied to
fabricate sheets or discs with limited thicknesses (the majority
between 200 and 500mm), no major additional implications
are expected to play a role in the applicability of imaging
methods compared with other fabrication methods.
Sintering. Sintering is mainly applied for hard tissue en-
gineering and is based on the heat treatment of a powder to
make the nano- or microparticles partially fuse with each oth-
er.108–110 Sintered scaffolds cover a wide range of porosities
from 5% to 80% with pore size ranging from tens of microns to
submillimeter.88 Sintering is traditionally applied on ceramics,
but it has also shown its potential for other materials such as
metals, glasses, and certain polymers and composites (Fig. 1E).
Sintering can be applied locally with the use of lasers
(SLS), which allows the fabrication of scaffolds with CAD
geometries, as previously described in the section on rapid
prototyping technologies.97 When sintering is applied to
obtain a homogeneously dense construct of ceramic mate-
rials, imaging possibilities will be restricted to nonoptical
material penetrating methods, such as microcomputed to-
mography (CT) or magnetic resonance imaging (MRI).
When amorphous materials are utilized, optical methods
could be applied. However, the multiple interfaces of ma-
terial with culture medium upon in vitro culture will limit
the achievable resolution and imaging depths due to scatter
and diffraction.
Bottom-up approaches. Bottom-up approaches have
been recently introduced to overcome hurdles faced with
mm-sized 3D scaffolds caused by limited access of the
scaffold for surface or bulk modification and functionali-
zation, as well as for nutrient availability. These hurdles
include inhomogeneous cell distribution,111 necrotic
cores,112 a limited remodeling capacity, and a limited con-
trol of cell fate. In bottom-up approaches, materials and
cells are first combined at the cellular level and allowed to
form so-called building blocks before assembling into larger
clinical relevant-sized constructs. The formation and sec-
ondary assembly of these building blocks can be both cell
and material guided. Bottom-up designs have shown the
potential to construct tissues with defined properties, in-
cluding spatial and temporal control at a cellular level.113,114
The porosities and pore sizes are determined by the physical
properties of the individual units and by the assembling
properties and can in theory be ranging from *10% to 90%
and from nanometers to hundreds of micrometers, respec-
tively. With the freedom in modulating the sizes and shapes
of the building blocks, the most optimal porosity and pore
size per application can be easily fabricated.88 By creating
micrometer-scaled building blocks from cells combined




















































with biomaterials eventually comprising instructive capa-
cities, complex tissues can be created and mechanisms of
tissue development can be studied (Fig. 1F).115 When using
monodispersed spheres, compaction will be limited, intro-
ducing a high interconnectivity.116
Bottom-up approaches based on gel-like materials allow
the cells to reside in an ECM-mimicking matrix, retaining
their rounded morphology.114,117 The use of hydrogels and
engineered micro-objects has shown a high potential in in-
jectable systems to reduce the invasiveness of surgical
procedures in vivo and allow for controlled assembly to
achieve complex tissues in vitro. The applicability of im-
aging methods to monitor cell fate and tissue growth in
bottom-up engineered scaffolds is dependent on the optical
properties of the materials used, the ratio of material versus
tissue, and the density of the obtained 3D constructs.
Imaging Modalities
Imaging methods have gained growing interest over the
past decades in the field of tissue engineering. The impor-
tance of noninvasive monitoring of cell and tissue behavior
during culture, to be able to more rationally predict the
success of the construct upon implantation, has been widely
acknowledged.118
Conventional destructive quality assessment procedures
such as histological analysis are still the golden standard,
mostly because of their high spatial resolution and speci-
ficity. Yet, for these analyses, the engineered construct is
sacrificed, which constrains the ability to instantly and ac-
curately adapt culture conditions. Nondestructive technolo-
gies can overcome this inefficient and costly approach.
Imaging-based nondestructive technologies enable real-time
determination of parameters such as the cell number and
distribution and the tissue type, content, and distribution.
With these insights and understanding of culture conditions,
immediate optimization of culture parameters could be
carried out, which ultimately results in faster and more ef-
ficient procedures.
Generally, imaging modalities require changes in inter-
actions of electromagnetic or mechanical energy among
various substances to be able to retrieve contrast between
these substances (Fig. 2). These changes in interactions in-
clude changes in energy due to absorption, refraction, or
scattering.119,120 Parameters such as imaging depth, con-
trast, and spatial resolution achieved by a given imaging
modality are largely based on the type and frequency of
energy employed. The benefits and drawbacks of several
imaging methods in the context of monitoring in vitro
tissue-engineered constructs are described in the following
sections and summarized in Table 1. Additionally, to obtain
an impression of the capabilities of imaging methods, an
overview with examples of obtained imaging results is given
in Figure 3. In this study, we will outline some commonly
used and some more promising imaging modalities for as-
sessing in vitro tissue engineering constructs.
Electron beam imaging
The two most widely used electron beam-based imaging
methods in tissue engineering are scanning electron micros-
copy (SEM) and transmission electron microscopy (TEM).
SEM can provide high-resolution images up to a few nano-
meters, but has limitations with respect to penetration depth.121
In tissue engineering, SEM is mostly applied to assess scaf-
fold quality after fabrication before cell culture or implanta-
tion and after culture or implantation. SEM is often referred to
as destructive since conventional SEM requires dehydration
and fixation of biological samples.9,122 However, there are
SEM devices that have an environmental (ESEM) modality
such as cryo-SEM, in which hydrated unfixed tissues can be
studied.121,123–125 In a study of Doyle et al., cryo-SEM was
applied to study the morphology of colonies of fibroblasts on
PLA.126 Yan et al. imaged cell growth of mouse osteoblast
cells on plasma-treated PCL nanofibers in wet mode SEM.127
This method can not only be applied on large mm-sized
constructs but also ESEM will only reveal information from
the exterior surface of the construct.
Despite the benefits ESEM can offer over conventional
high-vacuum SEM, it is not extensively applied in the field of
tissue engineering, whereas it is a commonly used imaging
method in food industry and plant sciences. TEM requires
sample fixation and processing into thin sections and is there-
fore considered a destructive endpoint imaging method.128
Therefore, TEM has in our view no potential in noninvasive
monitoring of tissue growth or cell fate in 3D constructs.
Nuclear imaging
Nuclear-based imaging techniques have shown potential in
many in vivo applications such as visualization of lymphatic
and vascular systems.129 For in vitro applications, however,
to date, nuclear-based methods are not yet commonly applied.
The lateral resolution of nuclear imaging modalities is lim-
ited since most available devices are mainly optimized for
human-scale use with a resolution of 1–2 mm.130 To be
able to achieve contrast in nuclear-based imaging methods
FIG. 2. The electromagnetic prop-
erties of various imaging modalities
(left). Spatial resolutions and imaging
depths obtained by conventional im-
aging methods applied on tissue sam-
ples (right). Color images available
online at www.liebertpub.com/teb




















































such as single-photon emission computed tomography
(SPECT) and positron emission tomography (PET), ra-
dioactive agents are required.
Although PET and SPECT cannot yet provide single-cell
resolution, which would be desirable in monitoring cell fate
in tissue-engineered constructs, both methods could still be
valuable tools enabling cell cluster localization and cell
function in vivo and in vitro. For example, by labeling cells
with radioactive tracer molecules such as fluorine-18-
radiolabeled fluorodeoxyglucose (18F-FDG) or fluorine-18-
radiolabeled 9-[4-fluoro-3-(hydroxymethyl)butyl]guanine
(18F-FHBG) for PET imaging, noninvasive cell tracking is
aided (Fig. 3A).131,132 A drawback of 18F-FDG is the high
tracer elution rate from the cells,133 which makes this tracer
mainly applicable for short-time monitoring.134 In addition,
for SPECT, a library of tracers is developed, which can be
targeted to specific cell surface receptors, metabolites, or
genes.135–137 The addition of CT to PET or SPECT im-
aging has shown to allow precise anatomic coregistration
of functional information with anatomy in small animals.138
Recently, micro-SPECT was developed and compared with
micro-CT to image a whole-mouse skeleton; however, ana-
tomical atlas-based segmentation and image processing were
required to be able to reconstruct 3D models of the detected
skeleton (Fig. 3B).139 Furthermore, applying tools such as
pinhole collimators to improve SPECT resolution has the








Electron beam High vacuum - ++ ++ -- Sample preparation required, only surface
of sample can be observed
Electron beam Wet mode SEM – ++ – -- Only surface of sample can be observed
Electron beam Cryo-SEM – ++ + -- Only surface of sample can be observed
Electron beam TEM -- ++ ++ -- Sample preparation required, destructive
Nuclear PET ++ ++ -- ++ Radioactive agents required, optimized for
whole-body imaging, in combination with
CT anatomic coregistration of functional
information
Nuclear SPECT ++ ++ - ++ Radioactive agents required, optimized for
whole-body imaging, in combination with
CT anatomic coregistration of functional
information
Optical Stereomicro + – – - Reflection of light, only surface of (opaque)
sample can be observed
Optical Bright field ++ - + – Transillumination, only on thin and virtually
transparent constructs, low contrast on
biological materials
Optical Phase contrast ++ - + - Transillumination, only on thin and virtually
transparent constructs
Optical DIC ++ - + – Transillumination, only on thin and virtually
transparent constructs
Optical Fluorescence ++ - ++ – Various modalities available with a broad range
of imaging depths and resolutions. Application
of fluorescent labels is not always required
Optical MPM ++ - ++ + Deeper penetration depth than conventional
fluorescence microscopy
Optical SHG ++ – ++ + High photon densities required, moderate
phototoxicity, no fluorescent staining required
Optical Bioluminescence ++ – – ++ Transgenic animals or cell lines required
Optical OCT ++ – + – Label-free, can be combined with e.g., Doppler
velocimetry, suited for highly scattering matter
Optical Raman ++ - – – Label-free, spectroscopic: image conversion
required
Echo US ++ ++ - + Dependent on sound transmission properties
of sample
Light/sound PAM or PAT ++ – - ++ Not suitable for imaging bony tissues
or air-filled matter
X-ray Micro-CT – ++ – ++ Radiation applied
Magnetic MRI ++ ++ + ++ Often contrast agents are required
The symbols indicate applicability and/or quality of the method in the given situation. These indications are based on the authors’
interpretation of reported results.
—, not applicable/very low quality; –, limited applicable/low quality; –, somewhat applicable/reasonable quality; +, applicable/good
quality; ++, very applicable/very good quality. CT, computed tomography; DIC, differential interference contrast; MPM, multiphoton
microscopy; MRI, magnetic resonance imaging; OCT, optical coherence tomography; PAM, photoacoustic microscopy; PAT,
photoacoustic tomography; PET, positron emission tomography; SEM, scanning electron microscopy; SHG, second harmonic generation;
SPECT, single-photon emission computed tomography; TEM, transmission electron microscopy; US, ultrasound.




















































consequence that longer scanning times are required due to
reduced photon sensitivity.138 Overall, PET and SPECT have
high potential in clinics to add functional information on to
anatomical structures imaged by other imaging modalities.
Yet, the applicability of nuclear-based imaging methods on
in vitro tissue-engineered constructs with a sub-mm scale
resolution is to date still limited.
Optical imaging
Optical imaging is based on systems that measure the in-
teraction of light (*10 up to 400 nm for ultraviolet, 400 nm up
to 710 nm for visible light, and 710 nm to 1 mm for infrared
light) with matter. These interactions can show differences in
scatter, absorption, or luminescence, which depending on the
imaging modality, can be optically visible or can be displayed
after computing retrieved spectra into images.
Epi- and transillumination microscopy. In epi- and trans-
illumination microscopy, visible light is projected onto a
specimen and contrast or colors are dependent on absorp-
tion and reflection, scatter, and breaking of the light. Epi-
illumination modalities such as stereomicroscopy are applied
on opaque specimens, from which reflected light is captured
revealing information from the surface of the specimens only.
Commonly used transillumination microscopy-based imaging
FIG. 3. Examples of results of various imaging methods applied in vitro and in vivo for cell tracking or tissue or scaffold
characterization. (A) Nuclear-based imaging methods such as positron emission tomography can provide functional in-
formation on cells by the uptake of specifically labeled radioactive agents. This research was originally published in JNM131
ª by the Society of Nuclear Medicine and Molecular Imaging, Inc. (B) SPECT enables the imaging of hard tissue materials
in small animal models. By segmentation and image reconstruction, 3D anatomical models can be obtained.139 (C)
Differential interference contrast microscopy of in vitro cultured corneal fibroblasts on a disorganized reconstituted collagen
substrate to study collagen remodeling by fibroblasts.141 (D) Near-infrared fluorescence microscopy to study scaffold
degradation in vivo.153 (E) A multimodal image of a blood vessel in kidney tissue combining second harmonic generation
(blue) with two-photon excitation fluorescence (green) and coherent anti-Stokes Raman scattering (red). Image courtesy of
Eric Potma, University of California, Irvine. (F) Bioluminescence of luciferase expressed in hypertrophic cartilage and
trabecular bone in a transgenic mouse model. (G) Imaging of a lacZ-marked tumor and its associated microvasculature by
dual-wavelength acoustic-resolution photoacoustic microscopy in vivo.213 (H) Typical micro-CT images of osteoblasts after
21 days of culture on scaffolds consisting of hydroxyapatite and collagen in various ratios.225 (I) Human bone marrow
stromal cells and newly formed extracellular matrix (arrow, white) in an opaque 3D additive manufactured scaffold
(asterisk, black) imaged by magnetic resonance imaging.239 For all images, reprint permission was granted through a single-
use license (A, C–F, and H) or through the creative commons (CC-BY) license (B, G, and I). 3D, three-dimensional;
SPECT, single-photon emission computed tomography. Color images available online at www.liebertpub.com/teb




















































modalities are bright-field microscopy, phase-contrast mi-
croscopy,140 and differential interference contrast (DIC)
(Fig. 3C)141 microscopy, for which the applicability is re-
stricted to imaging two-dimensionally (2D) and in 3D to thin
(<300mm) and virtually transparent constructs.9
Bright-field microscopy renders most detail of living cells
invisible since there are no large differences in absorption
by the structures inside cells. Phase-contrast microscopy is
based on differences in refraction, which lead to a phase
delay in some of the light causing contrast in the images.
DIC imaging allows detailed microscopic examination of
the matrix texture and cell orientation in the plane of the
construct141 and can be applied to study dynamics in living
cells since this method is noninvasive and continuous.142
For several types of rapid prototyped scaffolds with longi-
tudinal pores cultured with cells in vitro, bright-field mi-
croscopy can still be applied to gain some insight in tissue
growth in the early phase. However, when the formed tissue
becomes denser, complete absorption of the light will inhibit
further assessment with transillumination-based methods.
Fluorescence microscopy. Optical fluorescent imaging
has developed into an important tool in biomedical research
both in vitro and in vivo. Fluorescence microscopy allows
for noninvasive cell and tissue monitoring, in which contrast
is offered by differences in autofluorescent properties of
tissue constructs due to endogenous fluorophores present in
all tissues,143–145 endocytosis or transfection of fluorescent
probes,146 or targeted fluorescent exogenous probes.147,148
Depending on the fluorescence modality applied (e.g., epi-
fluorescence, confocal fluorescence, multiphoton fluores-
cence) and the excitation wavelengths utilized, imaging
depths between submicron up to whole-animal imaging in
the cm scale can be achieved.149,150 The majority of studies
on cell fate, in which fluorescence microscopy is applied in
3D, are focused on in vivo cancer metastasis, cell homing,
and cell differentiation.151
Martin et al. showed that combining bright-field micros-
copy with fluorescent microscopy on ex vivo slices of un-
stained bone scaffolds enables the quantification of formed
bone matrix by autofluorescence detection.144 Cowles et al.
applied near-infrared (NIR) optical imaging with a bone-
specific NIR-targeted probe to noninvasively study miner-
alization of tissue-engineered bone constructs over time
in vivo.152 By the application of NIR, imaging problems
related to autofluorescence from the native tissue can be
eliminated.138 In another study, NIR fluorescent imaging
was applied to monitor scaffold degradation in vivo.153
For in vitro cell studies, de Mel et al. showed that bio-
functionalized quantum dots have great potential for live
monitoring of endothelial progenitor cells seeded in mm-
sized polymeric scaffolds and cultured in a pulsatile flow
bioreactor for vascular tissue engineering applications.154
Although, whole-body imaging of mice was shown to be
feasible, the spatial resolution with such imaging depths
drastically decreased from submicron to mm scale, in which
only clusters of cells were detectable.149,155 Recent studies
have shown in vivo assessment of cell migration in living
mice with a subcellular resolution.156,157 Although the ap-
plied methods are classified as noninvasive and label-free,
the continuous expression of fluorescent proteins to monitor
cellular migration over time with a subcellular resolution
requires genetic modifications in the applied cell lines or
animals. For more information on the current state of the art
in live cell imaging in whole animals by the application of
fluorescent proteins, one can refer to a review from Hoff-
man.158 Most conventional fluorescent microscopes found in
tissue engineering laboratories have limited penetration
depths of both the excitation and emission wavelengths
when applied on dense tissues such as cartilage and bone
and on opaque materials.
Multiphoton microscopy and second harmonic genera-
tion. Fluorescence microscopy has long been used for vi-
sualizing cells and angiogenesis in scaffolds as described
earlier. However, due to strong light scattering, especially in
the presence of blood, conventional fluorescence microscopy
shows poor tissue penetration of several hundred microme-
ters. Multiphoton microscopy (MPM) has shown to partly
overcome this limitation and allows imaging two to three
times deeper into specimens and enables optical sectioning
into stacks for 3D reconstruction.159,160 For MPM, some
specialized optical effects can be applied to enable label-free
imaging of cells within scaffolds without the requirement of
sample preparation.12 Imaging with second harmonic gener-
ation (SHG) requires high photon densities and, to avoid
tissue damage, short pulses of laser light, as provided by
picosecond or femtosecond multiphoton lasers.142
Conventionally available multiphoton lasers generated
light with wavelengths ranging from 700 to nearly 1000 nm.
The emission detection for SHG will be in the range of 350–
500 nm when these lasers are applied. In biological speci-
mens, SHG signals are obtained from proteins that contain a
high amount of higher-order structures, for example, from
alpha-helical structures, which are present in collagens and
elastic fibers.161 Because of its high resolution and pene-
tration depth, yet with only moderate phototoxicity, this
technique holds strong promise for future developments in
live cell and matrix research exploiting nonlinear molecular
characteristics of molecules and tissues.
Sun et al. have applied a combinatorial modality of MPM
with SHG imaging to investigate the nonlinear optical prop-
erties of five commercially available scaffold materials: a
collagen composite scaffold, a bone graft matrix strip (col-
lagraft), an open-cell PLA scaffold, a PGA scaffold, and a
nylon mesh.162 They showed that MPM is effective in pro-
viding spectrally resolved morphological information of the
materials and hypothesized (yet did not show) that this
method can be used to study cell–matrix interactions when
cells are cultured on these scaffolds. In other studies, MPM
was applied on tissue-engineered constructs and was com-
bined with SHG imaging to noninvasively retrieve insights on
the interaction between scaffolds and tissues or between
scaffolds and cells in vitro and in vivo.118,163,164 For example,
in the study of Lee et al., ECM formation on PGA electro-
spun scaffolds was followed and showed to initially align
along the scaffold fibers, while after inducing chondrogenesis
for several weeks, scaffold reorganization was observed.118
Pena et al. have also shown scaffold remodeling during
culture, in this case, in collagen matrices seeded with fi-
broblasts.164 Furthermore, combining SHG with MPM
showed that among other structural parameters, the molec-
ular orientation of the sample and the overall beta sheet
content could be detected.145,165 Overall, combinatorial




















































imaging modalities based on MPM and SHG provide in-
formation about materials present in tissue-engineered
constructs, ECM components such as collagens, and cells
simultaneously in separate channels.145,166 This allows for
adequate (automated) image analysis of specific (labeled)
components per channel. Ultimately, this enables novel
approaches to directly modify culture parameters to induce
or prevent certain cell and tissue fate-related processes.
Bioluminescence. Bioluminescence (BLI) uses light
emission produced through enzymatic catalysis of, for ex-
ample, luciferin by a luciferase enzyme. The principle has
proven useful to monitor gene expression and cellular activ-
ities both in vitro and in small animal models in vivo.167–169
Several studies have shown the correlation between luciferase
activity and the number of cells within tissues in vivo or
scaffolds in vitro.170–173 Logeart-Avramoglou et al. have
shown the quantification and characterization of lumines-
cence from live cells and cell lysates after culture on poly-
meric translucent soft hydrogels and on opaque hard
ceramics.174 Olivo et al. reported a further correlation be-
tween luciferase activity, the number of cells, and bone for-
mation in vivo.175 In another study, osteogenesis was assessed
by monitoring gene expression-dependent BLI by coupling of
luciferase reporters to the promoter of osteocalcin.172,176–178
Because of its high sensitivity, BLI technology has recently
proven its usefulness in tracking stem cells on material
scaffolds transplanted in live animals for tissue engineering
purposes.178 One of the limitations of BLI is the limited
resolution, which can range from tens of microns to milli-
meters. Furthermore, to the best of our knowledge, the current
technology to image BLI does not allow for retrieving 3D
imaging stacks of tissues and tissue constructs, thereby lim-
iting the reconstruction modalities of 3D tissue development.
Optical coherence tomography. Optical coherence to-
mography (OCT) was first introduced by Huang et al. for the
assessment of biological tissues.179 OCT has been used for
label-free imaging of tissue/scaffold constructs at a relatively
high resolution in the submicron range.9 Depending on the type
of scaffold, it can be rather difficult to distinguish between the
tissue and the scaffold when their refractive indices are simi-
lar.180,181 A light beam from a broad bandwidth light source is
focused into a sample and the time that the light takes to return
from the specimen to the detector is measured. This echo time-
of-flight information enables the determination of the depth in
the sample from where the light was scattered.120,179,182
OCT is applied in the field of tissue engineering to
characterize the architecture of scaffolds, including porosity,
pore distribution, and interconnectivity before cell cul-
ture.183 In deep tissue imaging, OCT is one of the most used
optical imaging modalities for its high spatial resolution of
<15 mm in scattering matter at depths up to 2 mm.184,185
Wang et al. applied OCT to assess scaffold-assisted wound
healing in mice and compared their results with conven-
tional H&E staining.186 Tissue development in vitro was
monitored with OCT by detecting an increase in back-
scattered light over time.187 In in vitro tissue engineering,
OCT combined with Doppler velocimetry has been applied
for characterization of flow in engineered tissues, such as
artificial blood vessels, by increasing the obtained contrast
compared with conventional OCT.188,189
In another study of Liang et al., three other combinatorial
modalities have been introduced and evaluated for tissue
engineering applications, namely OCT and multiphoton
microscopy (OCM/MPM), optical coherence elastography
(OCE), and spectroscopic OCT (SOCT).181 OCM/MPM
enables imaging at greater depths in highly scattering tissues
by combining the spatial optical sectioning capabilities of
confocal microscopy with coherence gating and rejection of
multiply scattered photons within one modality, resulting in
high sensitivity and high contrast.181 This integrated system
allows to obtain microstructural and functional properties of
engineered tissues simultaneously and to display the data
within one representation.
OCE reveals information on the biomechanical properties
of tissues by applying mechanical stimulation to the mate-
rial with simultaneous OCT detection. Dependent on the
optical properties of the tissues, the main features of OCE
can include millimeters of penetration depth and spatial
resolution in the micron scale. SOCT is based on spectral
analysis and intensity analysis of backscattered light from
tissues. Similar to OCM, OCE, and conventional OCT,
SOCT can obtain spatial resolutions in the micron scale.190
In conventional OCT, no exogenous fluorophores are re-
quired since OCT relies on variations in indices of refraction
and optical scattering for image contrast.185 Therefore, OCT
can be considered a noninvasive, label-free imaging mo-
dality, enabling cellular imaging within living specimens
over time without loss of viability.191
Raman microspectroscopy. Raman microspectroscopy is
a label-free spectroscopic technique, which does not require
special sample preparation and can be used for noninvasive
characterization of cell and tissue biochemistry.192,193 Careful
selection of suitable laser wavelengths and laser intensity can
eliminate cell damage, allowing for the study of cells without
inadvertently changing their phenotype or behavior caused by
photo damage.194–196 Raman spectral studies have been per-
formed for structural analysis of ECM components such as
collagen197 and proteoglycans.192,198 Raman peaks at distinct
wavelengths exist, for example, for different types of carbon–
carbon bonds, amide, carboxyl, sulfhydryl, and phenol groups.120
In some relatively complex samples, Raman peaks could
be characterized by entire molecules, such as carotenoids,
glucose, and hydroxyapatite.120 Spectral information retrieved
by scanning specimens over a certain area, optionally con-
focal, can be computed and displayed as 3D cluster images.199
Raman spectroscopy and Raman spectroscopy-based imaging
have been successfully applied in several tissue engineering
applications, for example, by monitoring chondrocyte be-
havior on bioactive scaffolds.200 Boyd et al. have utilized a
benchtop macro-Raman spectrometer with high-throughput
screening capability to examine spectral differences between
well-characterized cell lines (two types of osteosarcoma cells,
human dermal fibroblasts and human embryonic lung epi-
thelial cells) and the effects of cellular death.201
Ultrasound
Ultrasound (US)-based imaging is in principal similar to
OCT except that acoustic waves are used instead of NIR
light.182 Compared with OCT, clinical US has a lower reso-
lution, but higher penetration depth. Although US imaging is




















































widely applied in the clinics, not much research has been
reported on applying US methods on in vitro cultured scaf-
folds. US-based monitoring methods have, similarly to X-ray-
based micro-CT, OCT, and MRI, already been applied to
nondestructively assess scaffold properties during and after
fabrication.202,203
Mather et al. applied ultrasonic pulse-echo reflectometry
to monitor changes in acoustic impedance of poly-(D,L-
lactic acid)-based scaffolds during supercritical scaffold
fabrication.202 Kim et al. introduced US elasticity imaging
on tissue-engineered constructs to monitor scaffold degra-
dation in vitro and in vivo with an axial and lateral resolu-
tion of *250 and 500 mm, respectively.203 Yet, both these
methods did not provide sufficient spatiotemporal informa-
tion on the scaffold structure to be able to draw conclusions
on tissue development throughout a 3D construct.
Rice et al. opted to use US to monitor cartilaginous ma-
trix development in chondrocyte-seeded PEG hydrogels
in vitro.204 Kreitz et al. have also evaluated the potential of
US for quantitative in vitro monitoring of tissue develop-
ment in a hydrogel-based 3D tissue-engineered construct.
They showed a correlation between the gray-scale values of
the obtained images with hydroxyproline content, which is a
marker of collagen formation.205
In a study of Fite et al., US backscatter microscopy (UBM)
was combined with time-resolved fluorescence to follow the
progression of tissue maturation along the chondrogenic lin-
eage by monitoring collagen type-2 production and by de-
tecting changes in mechanical properties of PLGA-based
constructs upon in vitro culture.206 UBM can provide struc-
tural information, respectively, with an axial and lateral res-
olution of *30 and 65mm that can be correlated with tissue
microstructure and construct stiffness, which can be a mea-
sure for the functionality of cartilage and bone-like tissue
constructs.206 Overall, the applicability of US-based imaging
methods to monitor tissue growth in mm-sized tissue-
engineered constructs highly depends on the aimed resolution
and imaging depth, the targeted tissue type, and the sound
transmission properties of these tissues and scaffold materials.
Photoacoustic tomography and photoacoustic
microscopy
Photoacoustic tomography (PAT) is a relatively novel, but
fast developing, clinically applied noninvasive and nonioniz-
ing method to monitor tissues in vivo and to detect, for ex-
ample, blood oxygenation in situ.207–210 The method is based
on the collection of ultrasonic waves resulting from heat ex-
pansion of tissues after absorption of laser irradiation within
those tissues.211 Large imaging depths up to *7 cm can be
achieved since the light only has to travel in one direction and
will result in a sound wave upon absorption.212 In PAT and
photoacoustic microscopy (PAM), the spatial resolution cor-
relates with the imaging depth and depends on the application,
yet a high depth-to-resolution ratio is maintained.213
Recently, a lateral resolution of 5 mm with an imaging
depth of 1 mm was obtained in highly scattering soft tis-
sue.214 By modulating the US detection frequency after laser
irradiation, PAT enables high-resolution imaging of bio-
logical structures with strong optical absorption contrasts.215
Although PAT and PAM are promising imaging methods for
in vivo applications, to date, just a few researchers have
investigated the potential of these methods for the field of
tissue engineering.130 Recently, PAM has been applied to
retrieve structural information on tissue engineering con-
structs in vitro216,217 and in vivo.122,214
Cai et al. incorporated carbon nanotubes in PLGA scaf-
folds to be able to obtain detectable contrast between the
polymeric scaffold and surrounding tissue.216 Other ap-
proaches have introduced NIR fluorescent proteins in vivo to
enable multicontrast next to already present endogenous
contrast agents such as hemoglobin.211 Such contrast agents
could also be applied to cells in vitro in tissue-engineered
constructs. To be able to extract more information from
tissue-engineered constructs, multimodal imaging techniques
can be applied. PAM could, for example, be combined with
US-based imaging as was already done in vivo.218
PAM has some limitations when imaging bony or air-
filled tissues caused by limited transparency and the absence
of a US wave transporting medium.214 Despite these two
major limitations, we still consider PAT and PAM to be
promising in analyzing biomaterial–tissue interactions in
soft tissue engineering applications in a completely nonin-
vasive and nonionizing manner.
X-ray-based micro-CT
Previously, X-rays were clinically applied as a fast di-
agnostic tool to obtain direct 3D whole-body projections on
2D photosensitive films. Currently, X-ray imaging com-
bined with CT can be applied in scanning mode at distinct
focal planes and with varying projection directions, enabling
3D reconstruction of the information.119,219,220 Depending
on the spot size of the generated X-ray, the beam properties,
and mostly the detector properties, nanometer scale resolu-
tion has been achieved.220
One of these CT modalities is micro-CT, which enables
tissue engineers and material scientists to evaluate the
morphological structures of their dry materials and fabri-
cated scaffolds nondestructively with high resolution and
accuracy.221–223 However, when polymeric scaffolds are
immersed in physiological fluids in vitro, or embedded
in vivo, wherein fluids perfuse through the scaffolds, the
contrast of micro-CT images has shown to be poor.216
Similar to MRI, micro-CT is also capable of distin-
guishing soft tissue material from harder mineralized tis-
sues.216,224 However, instead of contrast resulting from
changes in proton dynamics, X-ray contrast is the result
from differences in absorption, refraction, and/or scattering
properties of the materials. Bone, fibrous tissue, and ceramic
scaffolds present different coefficients of X-ray absorption,
therefore their 3D structures can be separated and corre-
sponding quantitative data such as bone volume, thickness,
growth, destruction, remodeling, and changes in bone den-
sity can be obtained.223,225 However, contrast between dis-
tinct types of soft tissue with similar X-ray attenuation is
limited226 and requires high cell densities.224
One approach to improve contrast between various soft tis-
sues is by the application of contrast agents.11 Tissue engi-
neering studies that do not assess mineralization often require
those toxic contrast agents or sample processing before imag-
ing. Unfortunately, most stained scaffolds are no longer usable
for culture due to high toxicity of the applied contrast agents.
Another approach to improve contrast is by combining micro-




















































CT with, for example, X-ray phase contrast. When these contrast-
related challenges can be overcome, monitoring of soft tissues
and live cells during scaffold culture can be a major future
application.6,227,228 Zhu et al. have shown the application of
X-ray diffraction-enhanced imaging (DEI) on the character-
ization of rapid prototyped scaffold geometry, chitosan
scaffold structure, and on muscle tissue morphology.228 With
the latter, they showed the outstanding capacity of DEI
to better image low-contrast soft tissues compared with both
radiography and in-line phase-contrast imaging.
Magnetic resonance imaging
Applications of MRI are often described when methods for
3D noninvasive imaging of nontransparent biological mate-
rials in the mm scale with relatively high resolution are re-
viewed.4,119,229 MRI can be applied either label-free or with
targeted magnetic beads, for example, to be able to track or
localize specific components or cells.230–232 Contrast in MRI
images is based on proton densities and differences in the spin
phase and relaxation time of these protons, among others, due
to variations in tissue hydration or water/lipid ratios.233
MRI has shown to be a promising imaging modality for
the assessment of musculoskeletal tissue-engineered con-
structs.7,234–239 In a study of Washburn et al., for instance,
an inverse relationship between MR relaxation times and
mineral concentration was found after culturing osteoblasts
on poly-(ethyl methacrylate) scaffolds.240 Chesnick et al.
showed that similar collagen mineralization results in car-
tilage tissue engineering.241 Other studies have shown a
correlation between collagen orientation and T2 relaxation
times in articular cartilage242,243and in tendons.244
Recently, advances have been made in the realization of
MRI-compatible bioreactors to be able to assess cell fate and
tissue growth longitudinally.245,246 Implementation of con-
trast agents in MRI enables cell tracking both in vitro and
in vivo.232,247–250 Immobilization of contrast agents on na-
noparticles is required for cell labeling through endocyto-
sis.251,252 Upon endocytosis, accumulation of the agent
leads to a darker or brighter signal, which will either reduce
or increase the contrast between the labeled cells and the
scaffolds, depending on the type of contrast agent used.253
Although MRI seems to be very promising in noninvasive
tissue construct quality assessment, this technology has not
yet become part of standard laboratory equipment.254 To
increase the signal-to-noise ratio in a voxel, and conse-
quently increase the spatial resolution, the use of high-field
MRI and long scanning times are required. Devices capable
of applying sufficient magnetic field strengths for micro-
MRI are expensive and not yet developed to fit in standard
tissue engineering laboratories.255,256
Discussion and Future Outlook
The need for novel approaches to monitor the cell and
tissue-related parameters that play a major role in the suc-
cess and quality of tissue-engineered constructs is well ac-
knowledged. This monitoring is not only pivotal for the
assessment of the engineered construct before implantation
but can also aid in the optimization of the culture conditions.
By gaining real-time insights in cell and tissue fate, direct
interventions could be foreseen, which would increase the
efficiency and decrease the costs of the chosen tissue engi-
neering approach. These insights are expected to be of even
greater value when spatiotemporal information is revealed.
In the past few decades, many scientists have put efforts
in developing and optimizing noninvasive methods to assess
tissue growth, cell fate, and scaffold integrity in vivo and
in vitro. Despite all these advances reviewed here, the most
applied method for the evaluation of the performance of a
tissue-engineered construct still remains destructive histo-
logical analysis. One of the main reasons for this being that
the golden standard has wide applicability on different types
of tissues, materials, and cells. Moreover, histological
analysis allows for multicolored labeling of tissue sections,
providing functional information with high accuracy, spec-
ificity, and resolution. Yet, some imaging modalities have
already shown to perform similar or even better in the
characterization of cell functionality in specific samples.
Depending on the application, location, and size of the
tissue-engineered construct, a specific imaging modality
could be chosen and optimized to obtain the desired infor-
mation without the need to disrupt the sample.
Recent developments in multimodal imaging will help to
overcome specific method-based limitations by combining
the benefits of each individual imaging method. Further-
more, incorporation of sensor-based information can further
move forward the comprehensiveness of retrieved infor-
mation from a single sample during culture. One can think
of cell localization and oxygen concentration by multimodal
imaging within a 3D construct cultured in a bioreactor257
and subsequent cell functionality determination by detecting
protein secretion with protein-specific circuitry integrated
sensors.258,259 Wireless nanoscale biosensors have been
developed, which in theory could be incorporated within a
scaffold, revealing information with a certain spatiotemporal
resolution.260,261 Ultimately, these sensors could be combined
with actuators, resulting in a responsive autonomous system
capable of locally providing instructive signals.
Parameters that are currently already monitored by sensor–
actuator-based systems are pH, oxygen saturation, and
temperature. However, observing recent advances in sensor–
actuator technology, we think that protein secretion, surface
marker expression, or even gene expression will be included
in the next generation of targeted parameters.
The combination of this information could allow a tissue
engineer to adapt its culture conditions while following the
outcomes in real time. Ultimately, monitoring to automate
production successfully would require integrated control sys-
tems with built-in data analysis and programmed parameter
adaptations.
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